↓ Skip to main content

Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer

Overview of attention for article published in Frontiers in immunology, September 2023
Altmetric Badge

Mentioned by

twitter
1 X user
reddit
1 Redditor

Readers on

mendeley
4 Mendeley